Variant report
Variant | nsv961720 |
---|---|
Chromosome Location | chr2:56937541-56942228 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:56940349..56941971-chr2:56943071..56945568,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs578164640 | chr2:56937543-56937544 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs183266593 | chr2:56937622-56937623 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs554182495 | chr2:56937719-56937720 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs575572661 | chr2:56937832-56937833 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs111868277 | chr2:56937872-56937873 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs72237043 | chr2:56937915-56937916 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs542743737 | chr2:56937927-56937928 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs569092514 | chr2:56937931-56937932 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs200944736 | chr2:56937932-56937933 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs562617196 | chr2:56937934-56937935 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs187836015 | chr2:56937935-56937936 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs545150151 | chr2:56937937-56937938 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs565037745 | chr2:56937957-56937958 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs193131132 | chr2:56938098-56938099 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs149576910 | chr2:56938134-56938135 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs7577678 | chr2:56938135-56938136 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs182852777 | chr2:56938145-56938146 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs549924707 | chr2:56938189-56938190 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs555991440 | chr2:56938229-56938230 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs144239935 | chr2:56938340-56938341 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs148715934 | chr2:56938370-56938371 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs551901943 | chr2:56938400-56938401 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs575939197 | chr2:56938410-56938411 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs577985018 | chr2:56938421-56938422 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs376341817 | chr2:56938468-56938469 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs142471146 | chr2:56938513-56938514 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs187752591 | chr2:56938520-56938521 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs534547319 | chr2:56938549-56938550 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs554152638 | chr2:56938554-56938555 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs573722471 | chr2:56938585-56938586 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs192828696 | chr2:56938589-56938590 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs183988060 | chr2:56938647-56938648 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs576083502 | chr2:56938747-56938748 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs545169924 | chr2:56938751-56938752 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs565129638 | chr2:56938854-56938855 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs74422805 | chr2:56938875-56938876 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs146872858 | chr2:56938905-56938906 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs139738812 | chr2:56938914-56938915 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs188822740 | chr2:56938950-56938951 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs542095131 | chr2:56938972-56938973 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs572044124 | chr2:56939004-56939005 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs192149654 | chr2:56939023-56939024 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs540737581 | chr2:56939044-56939045 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs374667963 | chr2:56939070-56939071 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs184455260 | chr2:56939139-56939140 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs13416797 | chr2:56939144-56939145 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs571841819 | chr2:56939155-56939156 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs534106454 | chr2:56939197-56939198 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs146592880 | chr2:56939280-56939281 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs140293506 | chr2:56939312-56939313 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
Mental retardation | 19951919 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Microcephaly | 20799320 | CNVD |
camptodactyly | 20799320 | CNVD |
cognitive delay | 20799320 | CNVD |
prenatal and postnatal growth deficiency | 20799320 | CNVD |
ptosis of eyelids | 20799320 | CNVD |
Maculopathy | 20981449 | CNVD |
2p16.1 microdeletion syndrome | 22283845 | CNVD |
Autism | 22579565 | CNVD |
Autism | 16963482 | CNVD |
Autism | 21750575 | CNVD |
idiopathic intellectual disability | 16963482 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Follicular lymphoma | 17699855 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:56932200-56943000 | Weak transcription | Psoas Muscle | Psoas |
2 | chr2:56933800-56940400 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
3 | chr2:56940200-56940400 | Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
4 | chr2:56940200-56940400 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
5 | chr2:56940200-56941400 | Enhancers | Skeletal Muscle Female | skeletal muscle |
6 | chr2:56940200-56942000 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
7 | chr2:56940200-56942000 | Enhancers | Muscle Satellite Cultured Cells | -- |
8 | chr2:56940200-56943200 | Enhancers | Fetal Heart | heart |
9 | chr2:56940400-56940800 | Enhancers | HSMMtube | muscle |
10 | chr2:56940400-56941000 | Flanking Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
11 | chr2:56940400-56941000 | Enhancers | Osteobl | bone |
12 | chr2:56940400-56941800 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
13 | chr2:56940400-56942000 | Flanking Active TSS | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
14 | chr2:56940600-56941800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
15 | chr2:56941000-56942000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
16 | chr2:56941200-56941400 | Enhancers | Skeletal Muscle Male | skeletal muscle |
17 | chr2:56941200-56941800 | Enhancers | NH-A | brain |
18 | chr2:56941400-56942600 | Weak transcription | Skeletal Muscle Female | skeletal muscle |
19 | chr2:56941400-56945600 | Weak transcription | Skeletal Muscle Male | skeletal muscle |
20 | chr2:56942000-56942400 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
21 | chr2:56942000-56942600 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |